Histion, LLC
Histion, LLC operates within Inotiv, Inc., a publicly traded nonclinical CRO providing drug discovery, safety assessment, research models, and Teklad laboratory diets to pharmaceutical, biotechnology, government, and academic customers worldwide.
- Company typePublic
- Founded2006
- HeadquartersEverett, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Histion, LLC does
Histion, LLC operates within Inotiv, Inc. (NASDAQ: NOTV), a publicly traded Discovery and Development Contract Research Organization headquartered in West Lafayette, Indiana, with operations spanning Everett and broader U.S. and global markets. The company delivers nonclinical testing services, research models, and laboratory analysis solutions across the drug development continuum from discovery through IND-enabling and pre-marketing authorization. Its service portfolio is organized into three primary lines: Discovery and Translational Sciences (disease pharmacology, DMPK, bioanalysis, cell and molecular biology, computational toxicology, toxicogenomics, targeted proteomics, histology and pathology); Safety Assessment (general and genetic toxicology, safety pharmacology, DART, carcinogenicity, GLP bioanalysis, medical device testing, SEND, cell and gene therapy); and Research Models and Services (genetically engineered models, contract breeding, surgical services, custom antibody production, biospecimen, genetic testing), supplemented by the Teklad sub-brand of laboratory animal diets, bedding, and welfareplus+ enrichment products.
The underlying technology stack combines GLP and non-GLP compliant laboratory infrastructure with proprietary customer-facing platforms, including the LabTracks web portal for project data and task management and the Eusoft Labs LIMS for health monitoring and sample tracking. Digital pathology is delivered via whole slide imaging paired with AI-driven quantitative image analysis, while ADC target quantification is performed via mass spectrometry assays covering 27 oncology and other targets. Revenue is generated through three mechanics: professional services contracts for CRO studies, one-time/model-based sales of research models and related services, and product sales of Teklad diets, bedding, and enrichment. Pricing is primarily quote-based for CRO services, with specialized tiers for NCI grantees and promotional pricing for new academic customers. Distribution runs through direct enterprise sales globally, online ordering for Teklad products, self-service customer portals, and a specialized NCI Grantee program. Customer segments are pharmaceutical and biotechnology companies (primary), plus government agencies, academic institutions, and life science organizations.
Histion, LLC firmographics
Firmographics- Name
- Histion, LLC
- Legal name
- Inotiv, Inc.
- Website
- https://inotiv.com
- Company type
- Public
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Histion, LLC operates within Inotiv, Inc., a publicly traded nonclinical CRO providing drug discovery, safety assessment, research models, and Teklad laboratory diets to pharmaceutical, biotechnology, government, and academic customers worldwide.
- Ownership category
- akta.pro rank
Histion, LLC industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Pathology & Histopathology Services (HLAGAFAI)
- akta.pro secondary industries
- Anatomic Pathology & Histopathology (Trial Support) (HLAGAEAC), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)
Keywords
Where Histion, LLC is headquartered
LocationHeadquarters
- HQ city
- Everett
- HQ country
- United States
- HQ region
- North America
Markets served
Histion, LLC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Contract Research Services: Inotiv generates revenue through nonclinical contract research services spanning discovery, IND-enabling, and preclinical development phases. Services include toxicology, bioanalysis, pathology, DMPK, and safety assessment studies conducted under GLP and non-GLP conditions.
- Research Models and Related Services: Sale of research models (rodents and other species) along with supporting services including genetically engineered models, contract breeding, surgical services, genetic testing, and biospecimen services.
- Laboratory Animal Diets and Supplies: Sale of Teklad laboratory animal diets (standard, custom, medicated), bedding, and environmental enrichment products for research animal colonies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | NCI Grantee Pricing |
| Other | Pay-as-you-go | Grantee Promotion - New Customer Discount |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Histion, LLC product offering
Product offeringCore offering
Histion, LLC provides scientific and technical expertise and develops products for the Medical Device, Pharmaceutical, and Biotechnology Industries. Operating within Inotiv as a Discovery and Development Contract Research Organization (CRO), Histion delivers nonclinical testing, medical device testing, histology and pathology services, surgical support, and research model-related services across the drug and device development continuum.
Differentiator
Problem solved
Functional benefit
Brands
- Teklad: Laboratory animal diets, bedding, and enrichment products including standard natural ingredient diets, custom research diets, medicated diets, and bedding/enrichment products.
Products and services
- Medical Device Testing and Surgical Support Nonclinical medical device testing services and surgical support for medical device manufacturers and developers across the product lifecycle.
- Histology and Pathology Services Histology and pathology evaluation services supporting drug discovery, toxicology studies, and preclinical development programs for pharmaceutical and biotechnology clients.
- Disease Pharmacology Services In vitro and in vivo disease pharmacology studies covering multiple therapeutic areas for pharmaceutical and biotech drug discovery programs.
- Genetic Toxicology Services (GLP and Non-GLP) Genetic toxicology testing under GLP and non-GLP conditions to support regulatory submissions and safety assessment programs.
- Research Models and Services Comprehensive range of research models including genetically engineered models and services (GEMS), contract breeding, surgical services, custom antibody production, biospecimen services, and genetic testing for research organizations.
- Teklad Laboratory Animal Diets Standard natural ingredient diets, custom research diets, and medicated diets for laboratory animal species with fixed formulation philosophy ensuring consistent batch-to-batch quality.
- Safety Assessment Services Nonclinical safety testing services including general toxicology, safety pharmacology, developmental and reproductive toxicology (DART), carcinogenicity studies, and bioanalysis under GLP conditions.
Quantifiable outcome
- First quarter fiscal 2026 revenue increased 0.8% to $120.9 million
Companies that use Histion, LLC
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles2 records
Histion, LLC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Histion, LLC partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CumberlandcoreCumberland is referenced as part of Inotiv's corporate structure, with a dedicated 'About Cumberland' page on the company website, suggesting a parent-subsidiary or affiliated company relationship.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Histion, LLC competitors and assessment
Company assessmentEmerging players
- HistoWiz: Specialized digital pathology and histology services provider for academic and biotech clients — emerging player directly competing in Histion's core histopathology services niche with a digital-first positioning.
- Flagship Biosciences: Specialty histopathology and tissue image analysis CRO focused on quantitative digital pathology for pharma/biotech drug development — emerging niche player with overlapping offerings to Histion's histology and digital pathology services.
Direct peers
- Charles River Laboratories: Global CRO offering discovery, safety assessment, and research models services — directly comparable to Histion/Inotiv's nonclinical testing and research models portfolio with histology capabilities embedded within its Safety Assessment segment.
- WuXi AppTec: China-headquartered CRO offering discovery, preclinical, and laboratory testing services with comparable capabilities in toxicology, DMPK, and safety assessment for global pharma customers.
- Labcorp: Major CRO via Labcorp Drug Development (formerly Covance) providing nonclinical, central lab, and bioanalytical services across the drug development lifecycle — directly comparable in histopathology and safety assessment work.
- Pharmaron: Global CRO providing drug discovery, preclinical, and CMC services — directly comparable as a CRO offering toxicology, DMPK, safety assessment, and laboratory services across discovery and development phases.
- ICON plc: Global CRO offering laboratory services, bioanalytical, and central lab capabilities — competes with Histion for outsourced preclinical histopathology and safety assessment work.
Broad incumbents
- Medpace: Mid-sized CRO offering full-service clinical development — relevant for outsourced drug development services model although it is more clinical-stage focused than Histion's preclinical histology niche.
- IQVIA: Largest global CRO with end-to-end clinical and preclinical capabilities — relevant comparable for size, customer base, and integrated service model even though it does not specialize narrowly in histopathology like Histion.
- Eurofins Scientific: Global testing services group with significant bioanalytical, central lab, and pharma services exposure — comparable as a contract laboratory services provider serving pharma/biotech sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Histion, LLC social profiles
Digital presenceHistion, LLC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Histion, LLC leadership team
Management profileNumber of profiles
Histion, LLC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Histion, LLC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Histion, LLC
What does Histion, LLC do?
Histion, LLC provides scientific and technical expertise and develops products for the Medical Device, Pharmaceutical, and Biotechnology Industries. Operating within Inotiv as a Discovery and Development Contract Research Organization (CRO), Histion delivers nonclinical testing, medical device testing, histology and pathology services, surgical support, and research model-related services across the drug and device development continuum.
Is Histion, LLC a public or private company?
Histion, LLC is a public company. It is classified as corporate owned and is currently operating.
When was Histion, LLC founded?
Histion, LLC was founded in 2006. It employs 11 to 50 people.
Where is Histion, LLC based?
Histion, LLC is headquartered in Everett, United States, in the North America region.
How does Histion, LLC make money?
Three revenue lines are on record. Contract Research Services are the primary driver. The others are research Models and Related Services and laboratory Animal Diets and Supplies.
Who are Histion, LLC's main competitors?
Emerging players on record are HistoWiz and Flagship Biosciences. Direct peers are Charles River Laboratories, WuXi AppTec, Labcorp, Pharmaron and ICON plc. Broad incumbents are Medpace, IQVIA and Eurofins Scientific.
Does Histion, LLC have an API?
No public API is recorded for Histion, LLC.
What industry is Histion, LLC in?
Histion, LLC's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAFAI, Pathology & Histopathology Services, with a secondary code of HLAGAEAC, Anatomic Pathology & Histopathology (Trial Support). Its NAICS code is 541714 and its SIC code is 8731.